Viz.ai is the latest company in the artificial intelligence space to draw attention from investors and raised about $21 million in a series A round.
The San Francisco, CA-based company has raised $26.6 million in a series C round to help further commercialize its Accuryn Monitoring System.
Verily and ResMed will form a joint venture to develop software solutions to identify and treat sleep apnea, as well as study the financial aspects of the disease if it goes undiagnosed and untreated.
Visura Technologies has received FDA clearance for a disposable camera that can help physicians view the upper airway during transesophageal echocardiogram (TEE) procedures.
Otsuka Holdings is set to acquire ReCor Medical for an undisclosed sum and follows Medtronic in a bid to get a renal denervation device on the market.
Biodesix picks up Integrated Diagnostics for an undisclosed sum, in an effort to build on its lung testing franchise.
The Clearwater, FL-based company said it will sell its electrosurgical offerings to Specialty Surgical Instrumentation, a subsidiary of Symmetry Surgical, for $97 million.
The Sunnyvale, CA-based company remains a titan in the surgical robotics space and has just made two separate moves that could help it maintain its top spot.
Boston Scientific is set to pick up Cryterion Medical, a specialist in AF treatment, and has acquired nearly half-a-dozen companies since March.
Medigus is working with A.M. Surgical to develop an integrated device that will provide surgical control and visualization during endoscopic carpal tunnel procedures.
The measure, which could be completed by 2019, comes on the heels of General Electric’s plans to turn GE Healthcare into a separate company.
M&A activity in the liquid biopsy space is picking up as Bio-Techne said it will acquire Exosome Diagnostics for $250 million plus $325 million in potential milestones.